Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Urologic Oncology
Published September 26, 2026
Serum Galectin-3 as a complementary biomarker in non-muscle-invasive bladder cancer.
September 27, 2026
Medspoke
Medspoke
Urologic Oncology
Published September 26, 2026
00:00
--:--
Novel use of computed tomography-derived body composition to facilitate risk assessment in patien...
September 27, 2026
Share
Novel use of computed tomography-derived body composition to facilitate risk assessment in patients with bladder cancer.
https://www.medspoke.co/channel_journal?id=689&tap_id=14526
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Urology (the "Gold Journal")
Published September 26, 2026
Contrasting reasons for early termination between industry and non-industry-led clinical trials i...
September 27, 2026
Why are you reporting this TALK?
